Hengli Packaging solves the problem of labeling in harsh environment and helps the smooth production of Fosun COVID-19 vaccine
Release Date : 2021-07-01
In June 2021, Hengli Packaging officially signed a contract with Fosun Pharmaceutical on the labeling project of vaccine products, and reached a cooperation to help the smooth production of COVID-19 vaccine. This cooperation is not only a major breakthrough of Hengli Packaging in packaging under low temperature environment, but also another professional exploration and successful attempt of Hengli in pharmaceutical equipment, packaging equipment and other fields.
Since its establishment in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has developed rapidly, has a wide range of business fields, and is a multinational pharmaceutical and health industry group driven by innovation. It takes pharmacy as the core, explores and researches in the frontier technology field through independent research and development, cooperative development, licensing and introduction, and has achieved remarkable results. Since last year, the COVID-19 has been affecting the nerves of human beings all over the world, and the urgent need for vaccines is also an urgent problem to be solved at the moment. Under such a special background of the times, the COVID-19 vaccine, which was commissioned by Fosun, put into production and received key recommendations from the pharmaceutical and biological industry, has undoubtedly become the focus of attention inside and outside the industry.
Since all COVID-19 vaccines are produced and transported by cold chain, the ambient temperature during production is as low as – 20 ℃ – – 25 ℃. The harsh low temperature environment makes the objective experimental data of labeling equipment insufficient to support application, and also increases the difficulty of packaging and production. After several communications, Fosun Pharmaceutical found Hengli Packaging and hoped to find a solution to the difficulties. As a high-tech enterprise specializing in personalized packaging and providing customers with intelligent overall packaging technology solutions, Hengli Packaging, in the face of this new challenge, together with German Herma, spent about a month discussing the design scheme, actively looking for similar low temperature environments for testing, and comparing data differences under different environments to find a breakthrough based on years of experience. After dozens of attempts, with their own professional skills and perseverance, we finally got a feasible test result.
Herma H500 labeling station, the labeling machine for COVID-19 vaccine produced by Fosun agent, is manufactured and provided by German century old brand Herma Co., Ltd. It is also an important part of the labeling system developed by Hengli Packaging for Fosun. As an expert in the field of self-adhesive technology, the machine developed by Hema has made great innovations in intelligence and labeling speed. Powerful, flexible and efficient are the advantages of this machine. In manufacturing, Hema adopts innovative components, which increases the labeling speed by 25%, and the fastest speed can reach 200m/min. Moreover, this machine is applicable to a wide range of label sizes, and its powerful versatility can make it quickly and easily put into various application scenarios. Hengli Packaging, as the partner of German Hema Co., Ltd. in China’s pharmaceutical/health care products and other fields, has solved the problem of low-temperature labeling of COVID-19 vaccine, giving Fosun Pharmaceutical a satisfactory answer.
Only with persistence can we be professional, and strive for excellence. Hengli Packaging has always taken professionalism and preciseness as the driving force for its own development. It takes users as teachers, friends, and wants to meet the needs of users. It strives to provide customers with powerful product services in the field of product packaging and intelligent manufacturing. In this cooperation with Shanghai Fosun Pharmaceutical, we have always carried out this core task, putting customer needs first, in order to create more development space and effective value for customers and the industry.
Hengli Packagingsolves the problem of labeling in harsh environment
and helps the smooth production of Fosun COVID-19 vaccine
Release Date:2021-07-01
In June 2021, Hengli Packaging officially signed a contract with Fosun Pharmaceutical on the labeling project of vaccine products, and reached a cooperation to help the smooth production of COVID-19 vaccine. This cooperation is not only a major breakthrough of Hengli Packaging in packaging under low temperature environment, but also another professional exploration and successful attempt of Hengli in pharmaceutical equipment, packaging equipment and other fields.
Since its establishment in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has developed rapidly, has a wide range of business fields, and is a multinational pharmaceutical and health industry group driven by innovation. It takes pharmacy as the core, explores and researches in the frontier technology field through independent research and development, cooperative development, licensing and introduction, and has achieved remarkable results. Since last year, the COVID-19 has been affecting the nerves of human beings all over the world, and the urgent need for vaccines is also an urgent problem to be solved at the moment. Under such a special background of the times, the COVID-19 vaccine, which was commissioned by Fosun, put into production and received key recommendations from the pharmaceutical and biological industry, has undoubtedly become the focus of attention inside and outside the industry.
Since all COVID-19 vaccines are produced and transported by cold chain, the ambient temperature during production is as low as – 20 ℃ – – 25 ℃. The harsh low temperature environment makes the objective experimental data of labeling equipment insufficient to support application, and also increases the difficulty of packaging and production. After several communications, Fosun Pharmaceutical found Hengli Packaging and hoped to find a solution to the difficulties. As a high-tech enterprise specializing in personalized packaging and providing customers with intelligent overall packaging technology solutions, Hengli Packaging, in the face of this new challenge, together with German Herma, spent about a month discussing the design scheme, actively looking for similar low temperature environments for testing, and comparing data differences under different environments to find a breakthrough based on years of experience. After dozens of attempts, with their own professional skills and perseverance, we finally got a feasible test result.
Herma H500 labeling station, the labeling machine for COVID-19 vaccine produced by Fosun agent, is manufactured and provided by German century old brand Herma Co., Ltd. It is also an important part of the labeling system developed by Hengli Packaging for Fosun. As an expert in the field of self-adhesive technology, the machine developed by Hema has made great innovations in intelligence and labeling speed. Powerful, flexible and efficient are the advantages of this machine. In manufacturing, Hema adopts innovative components, which increases the labeling speed by 25%, and the fastest speed can reach 200m/min. Moreover, this machine is applicable to a wide range of label sizes, and its powerful versatility can make it quickly and easily put into various application scenarios. Hengli Packaging, as the partner of German Hema Co., Ltd. in China’s pharmaceutical/health care products and other fields, has solved the problem of low-temperature labeling of COVID-19 vaccine, giving Fosun Pharmaceutical a satisfactory answer.
Only with persistence can we be professional, and strive for excellence. Hengli Packaging has always taken professionalism and preciseness as the driving force for its own development. It takes users as teachers, friends, and wants to meet the needs of users. It strives to provide customers with powerful product services in the field of product packaging and intelligent manufacturing. In this cooperation with Shanghai Fosun Pharmaceutical, we have always carried out this core task, putting customer needs first, in order to create more development space and effective value for customers and the industry.
HOT NEWS
HOT NEWS